217 related articles for article (PubMed ID: 34027602)
1. Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia.
Masurkar PP; Chatterjee S; Sherer JT; Aparasu RR
Drugs Aging; 2021 Jul; 38(7):593-602. PubMed ID: 34027602
[TBL] [Abstract][Full Text] [Related]
2. Risk of overactive bladder associated with cholinesterase inhibitors in dementia.
Masurkar PP; Chatterjee S; Sherer JT; Chen H; Johnson ML; Aparasu RR
J Am Geriatr Soc; 2022 Mar; 70(3):820-830. PubMed ID: 34854475
[TBL] [Abstract][Full Text] [Related]
3. Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study.
Masurkar PP; Chatterjee S; Sherer JT; Chen H; Johnson ML; Aparasu RR
Drugs Aging; 2022 Jun; 39(6):453-465. PubMed ID: 35666463
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic Initiation Among Older Dementia Patients Using Cholinesterase Inhibitors: A National Retrospective Cohort Study.
Rege S; Carnahan RM; Johnson ML; Chen H; Holmes HM; Aparasu RR
Drugs Aging; 2021 Jun; 38(6):493-502. PubMed ID: 33763822
[TBL] [Abstract][Full Text] [Related]
5. Risk of Mortality Associated with Non-selective Antimuscarinic medications in Older Adults with Dementia: a Retrospective Study.
Kachru N; Holmes HM; Johnson ML; Chen H; Aparasu RR
J Gen Intern Med; 2020 Jul; 35(7):2084-2093. PubMed ID: 32026255
[TBL] [Abstract][Full Text] [Related]
6. Comparative risk of adverse outcomes associated with nonselective and selective antimuscarinic medications in older adults with dementia and overactive bladder.
Kachru N; Holmes HM; Johnson ML; Chen H; Aparasu RR
Int J Geriatr Psychiatry; 2021 May; 36(5):684-696. PubMed ID: 33169433
[TBL] [Abstract][Full Text] [Related]
7. Risk of pneumonia in new users of cholinesterase inhibitors for dementia.
Lai EC; Wong MB; Iwata I; Zhang Y; Hsieh CY; Kao Yang YH; Setoguchi S
J Am Geriatr Soc; 2015 May; 63(5):869-76. PubMed ID: 25912671
[TBL] [Abstract][Full Text] [Related]
8. Factors Associated With Deprescribing Acetylcholinesterase Inhibitors in Older Nursing Home Residents With Severe Dementia.
Niznik JD; Zhao X; He M; Aspinall SL; Hanlon JT; Nace D; Thorpe JM; Thorpe CT
J Am Geriatr Soc; 2019 Sep; 67(9):1871-1879. PubMed ID: 31162642
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease.
Mantri S; Fullard M; Gray SL; Weintraub D; Hubbard RA; Hennessy S; Willis AW
JAMA Neurol; 2019 Jan; 76(1):41-49. PubMed ID: 30285047
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C
Health Technol Assess; 2012; 16(21):1-470. PubMed ID: 22541366
[TBL] [Abstract][Full Text] [Related]
11. Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease.
Cooke JR; Loredo JS; Liu L; Marler M; Corey-Bloom J; Fiorentino L; Harrison T; Ancoli-Israel S
Drugs Aging; 2006; 23(6):503-11. PubMed ID: 16872233
[TBL] [Abstract][Full Text] [Related]
12. Antimuscarinic use among older adults with dementia and overactive bladder: a Medicare beneficiaries study.
Kachru N; Holmes HM; Johnson ML; Chen H; Aparasu RR
Curr Med Res Opin; 2021 Aug; 37(8):1303-1313. PubMed ID: 33890538
[TBL] [Abstract][Full Text] [Related]
13. Comparative risk of cardiac arrhythmias associated with acetylcholinesterase inhibitors used in treatment of dementias - A narrative review.
Huang Y; Alsabbagh MW
Pharmacol Res Perspect; 2020 Aug; 8(4):e00622. PubMed ID: 32691984
[TBL] [Abstract][Full Text] [Related]
14. Effects of Acetylcholinesterase Inhibitors on Nutritional Status in Elderly Patients with Dementia: A 6-month Follow-up Study.
Soysal P; Isik AT
J Nutr Health Aging; 2016 Apr; 20(4):398-403. PubMed ID: 26999239
[TBL] [Abstract][Full Text] [Related]
15. Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study.
Santoro A; Siviero P; Minicuci N; Bellavista E; Mishto M; Olivieri F; Marchegiani F; Chiamenti AM; Benussi L; Ghidoni R; Nacmias B; Bagnoli S; Ginestroni A; Scarpino O; Feraco E; Gianni W; Cruciani G; Paganelli R; Di Iorio A; Scognamiglio M; Grimaldi LM; Gabelli C; Sorbi S; Binetti G; Crepaldi G; Franceschi C
CNS Drugs; 2010 Feb; 24(2):163-76. PubMed ID: 20088621
[TBL] [Abstract][Full Text] [Related]
16. Challenges in the Pharmacological Management of Nursing Home Residents with Overactive Bladder or Urinary Incontinence.
Zarowitz BJ; Allen C; O'Shea T; Tangalos EG; Berner T; Ouslander JG
J Am Geriatr Soc; 2015 Nov; 63(11):2298-307. PubMed ID: 26503458
[TBL] [Abstract][Full Text] [Related]
17. Association between long-term usage of acetylcholinesterase inhibitors and lung cancer in the elderly: a nationwide cohort study.
Liu CT; Yang CC; Chien WC; Chung CH; Tsai CS; Tsai YT; Lin CY; Lin YC; Chen YS; Tzeng NS
Sci Rep; 2022 Mar; 12(1):3531. PubMed ID: 35241672
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain.
Nazir J; Hakimi Z; Guelfucci F; Khemiri A; Fatoye F; Blázquez AMM; González MH
BMC Urol; 2018 Sep; 18(1):76. PubMed ID: 30180826
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder.
Andersson KE; Sarawate C; Kahler KH; Stanley EL; Kulkarni AS
BJU Int; 2010 Jul; 106(2):268-74. PubMed ID: 19922546
[TBL] [Abstract][Full Text] [Related]
20. Impact of acetylcholinesterase inhibitors on the occurrence of acute coronary syndrome in patients with dementia.
Wu PH; Lin YT; Hsu PC; Yang YH; Lin TH; Huang CT
Sci Rep; 2015 Nov; 5():15451. PubMed ID: 26577589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
